Description
The epidemiological association between diabetes and heart failure is well-established and the two entities are emerging as global threats, both individually and synergistically, to an aging population. The exploration of multiple proteins can shed light on pathophysiological pathways in both diabetes and cardiovascular disease. This can possibly provide novel diagnostic, prognostic, and hopefully therapeutic implications.The overall aim of this dissertation was to explore novel biomarkers in cardiometabolic disease especially in heart failure.
| Period | 2015 Jun 10 → 2020 Nov 27 |
|---|---|
| Examinee/Supervised person | John Molvin |
| Examination/Supervision held at | |
| Degree of Recognition | International |
Free keywords
- Biomarkers
- Cardiometaboliic disease
- Diabetes
- Heart failure
- Proteomics
Documents & Links
Related content
-
Research output
-
Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project
Research output: Contribution to journal › Article › peer-review
-
Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
Research output: Contribution to journal › Article › peer-review
-
Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease
Research output: Contribution to journal › Article › peer-review
-
Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients
Research output: Contribution to journal › Article › peer-review